One-year outcome of high-risk patients with acute myocardial infarction with or without diabetes: Data from the MISTRAL study  by Baldasseroni, Samuele et al.
366A ABSTRACTS - Myocardial Ischemia and Infarction JACC March 19,2003 
revealed a strong graded mortality relationship (Range: 1 .O to 23.1%, p c.0001, c-statis- 1.43). This study confirms, in a large unselected cohort of HR-pts with AMI, that D is a 
tic 0.73). The predidive capacity of the TRI was particularly strong in lhose receiving rep- significant independent predictor of poor prognosis. Neverthless, pts with D are often 
erfusion therapy (STEMI-IRS, Fig A). Moreover, in patients with NSTEMI, the risk index undertreated with aggressive mechanical or pharmacological therapy. 
also revealed a significant graded relationship with mortality (Fig 6). 
Conclusions: A simple risk index from baseline clinical variables routinely obtained at 
the first patient encounter predicted mortality in a heterogeneous group of patients pre- a l-I=*- 
senting with STEMI or NSTEMI. Despite differences in syndrome pathophysiology, this _M”R, 
risk index may prove valuable in the assessment of patients with STEMI or NSTEMI. Ln 
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Background : Previous studies confirmed ST segment resolution (RST) during fibrinolyijc 
therapy (FT) for ST elevation myocardial infarction as a convenient marker of reperfusion 
correlated to TIMI flow grade and TIMI myocardial perfusion grade. The RST at 60, 90 
and 160 min after repedusion therapy is known to identify low mortality group of 
patients.The TIMI risk score is a clinical, bedside, risk score developped to predrct 
STEMI 30 days mortality. 
Objectives : The aim of this study is to assess the relationship between TIMI risk score 
and 60 min RST. 
Method : A cohort of 726 patients were given pre-hospital FT for STEMI (pain to FT, 
mean time 120 min). ECG was performed prior starting FT (baseline ECG) and 60 min 
later. ECG were analized to isolate two classes of RST: no or worsening RST (~30%) 
and partial or complete RST ()=30%). TIMI risk score was calculated at pre-hospital pre- 
sentation. 30 days mortality was investigated for each class of RST and each level of 
TIMI risk score. 
Results: The results are shown in the table below, and expressed in number of patients. 
TIMI risk score and 60 min RST are independent 30 days mortality markers(p>0.05). 
Conclusion : The absence of relationship between TIMI risk score and 60 min RST for 
STEMI patients suggests that RST should be taken into account as an independent vari- 
able in a new scoring system. 










Death No RST RST Total 
1 29 71 106 
4 76 120 196 
5 41 a0 121 
9 39 79 113 
12 39 50 a9 
6 22 26 48 
5 14 14 28 
4 11 7 ia 
5 a 7 15 
51 279 449 728 
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Left bundle branch block (LBBB) complicates AMI diagnosis. Sgarbossa’s criteria devel- 
oped from GUSTO 1 to surmount this diagnostic challenge but have not been previously 
validated in a clinical trial. We evaluated their utility in the diagnosis and rusk stratifk?atlon 
of AMI patients (pts) in ASSENT 3. Methods: Baseline ECGs of ASSENT 3 pts were 
reviewed for LBBB by blinded core labs. Sequential ECGs (baselme, 60, 160 min & dis- 
charge) of LBBB pts were scored using Sgarbossa’s criteria (O-5) for AMI diagnosis. 
Results: 92(1.5%) pts had LBBB on baseline ECG: their 30-day death vs those without 
LBBB (n= 5932) was 14.1% vs 5.6% respectively (p=O.O03). More pts without peak CK 
>= 2x upper normal limit (UNL) had LBBB than those without LBBB (33.3% vs. 15.7%, 
p<O.OOl). Among 75 LBBB pts with peak CK data available, 30 day death tended to be 
lower among pts without peak CK rise than those with CK rise (4% versus la%, p=O.15). 
The table shows Sgarbossa’s score of >= 3 distribution (highly suggests AMI in the pres- 
ence of LBBB) and mortality. Sequenttal ECGs revealed that among 25 LBEB pts without 
peak CK rise, 15 pts did not have acute Ml on admission. 
Sgarbossa score ~3 Sgarbossa score <3 P value 
N=26 N=47 
Peak CK <2x 2 (7.2%) 23 (46.9%) <O.OOi 
Peak GK s=2x and 7 (14.9%) 
<=3x 
PeakCK>Bxandc=Sx 3 (10.7%) 7 (14.9%) 
Peak CK >5x 23 (62.1%) 10 (21.3%) 
30 day mortakty 6/28 (21.4%) 4147 (8.5%) 0.161 
Conclusion: Our findings validate the utrlity of Sgarbossa’s cntena for diagnosing AMI III 
the setting of LBBB. Sgarbossa’s criteria provide a sample and practical diagnostic 
approach to optimize risk- benefit of acute therapy in this diagnostically challenging 
group and contribute usefully to risk stratrfication in this high nsk population. 
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Pts with diabetes (D) have more often severe coronary arteriosclerosis with high risk 
IHR) of AMI and cardiac death. We studied in-hosoital and I-Year outcomes of HR ots 
Aith’AMI with or without D treated with reperfusion therapy (thrombolysis or primary-P&) 
or drua theraw. 2227 HR-ots with AMI <I2 h were recruited at 17 centres wrth. and 30 
without, feasibility of performing primary PCI (classified at HR having21 of the following 
characteristics: female r70 y, diabetic >70 y, Killip class >I, SBP <IO0 mmHg and heart 
rate >lOO b/m, z-4 leads with ST deviation, previous Q-wave AMI, contraindication to 
thrombolysis). 1795 pts (60.6%) had not D and 432 pts (19.4%) were diabetic: pts with D 
were more often females, older, with a history of cardiovascular disease, arrhythmias 
during hospital stay and heart failure at entry. Pts with D were less treated with reperfu- 
sion therapy (74.3% vs 63.0%, p<O.OOOi) and with betablockers at discharge (41.2% vs 
49.5%, p<O.O05). One year mortality and combined end-point (death+reAMl+heart fail- 
ure+angina) are showed in the figure. When we adjusted the 1 -year outcomes for all clin- 
ical, haemodynamic variables and therapy, D remained an independent prognostic 
predictor (death OR: 1.54, 95%CI 1.13-2.09: combined end-point OR: 1.13, 95%CI 0.69- 
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and 1996 
John 6. Kostis, Alan C. Wilson, Janet Lawrence-Nelson, Rajiv Ranjan, Nora M. 
Cosgrove, Clifton R. Lacy, Pearl D’Sa, UMDNJ-Robert Wood Johnson Medical School, 
New Brunswick, NJ 
Background: In-hospital mortality of acute myocardial infarction (Ml) has declined in the 
last 15 years. This study focuses on the outcome of patients after discharge. 
Methods: Using a statewide Ml database, we examined post-discharge mortality among 
30,341 Ml patients who were hospitalized in New Jersey from 1966 and 1996. 
Results: In 1996 patients were older and more likely to have non-Q MI. revascularization, 
comorbidity and shorter length of stay. Age adjusted one year mortality after discharge 
was higher in 1996 compared with 1966 (RR 1.06, 95% Cl 1.01-l .16). The increase per- 
sisted after adjustment for demographics, comorbidities, complications, procedures and 
age of infarction (RR 1.54, 95% Cl 1.42-1.67). The increased post-discharge mortality 
diminished the benefit of the marked decline of in-hospital mortality from 3.6% absolute 
